Continuous Hyperthermic Peritoneal Perfusion With Cisplatin Plus Intraperitoneal Paclitaxel and Fluorouracil Following Surgery in Treating Patients With Peritoneal Cancer

This study is currently recruiting participants.
Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Carcinoma of the Appendix
			Colorectal Cancer
			Peritoneal Cavity Cancer
2		Additional conditions recognized in this trial
			Carcinoma
			Colorectal Neoplasms
3		More general conditions related to this trial
			Colonic Diseases
			Digestive System Diseases
			Digestive System Neoplasms
			Gastrointestinal Diseases
			Gastrointestinal Neoplasms
			Intestinal Diseases
			Intestinal Neoplasms
			Neoplasms
			Neoplasms by Histologic Type
			Neoplasms by Site
			Neoplasms, Glandular and Epithelial
			Rectal Diseases
4		Interventions listed in this trial
			cisplatin
			fluorouracil
			paclitaxel
			adjuvant therapy
			conventional surgery
			hyperthermia treatment
5		More general drug interventions related to this trial
			Antimetabolites
			Antimetabolites, Antineoplastic
			Antimitotic Agents
			Antineoplastic Agents
			Antineoplastic Agents, Phytogenic
			Immunologic Factors
			Immunosuppressive Agents
			Mitosis Modulators
			Molecular Mechanisms of Pharmacological Action
			Pharmacologic Actions
			Physiological Effects of Drugs
			Radiation-Sensitizing Agents
			Therapeutic Uses
			Tubulin Modulators
6		Sponsors listed in this trial
			National Cancer Institute (NCI)